Sale!

Aspirin Resistance 11-Dehydrothromboxane B2 Test

Original price was: 3,060 د.إ.Current price is: 2,750 د.إ.

-10%

The “Aspirin Resistance 11-Dehydrothromboxane B2 Test” is a specialized diagnostic tool designed to assess the effectiveness of aspirin therapy in individuals. Aspirin is commonly prescribed to prevent blood clots, which can lead to heart attacks and strokes, by inhibiting the production of thromboxane, a molecule that plays a crucial role in clot formation. However, some individuals may not respond to aspirin treatment as expected, a condition known as aspirin resistance.

This test specifically measures the levels of 11-Dehydrothromboxane B2 in the urine, a stable metabolite of thromboxane, to evaluate how well aspirin is inhibiting thromboxane production in the body. Elevated levels of this metabolite may indicate that aspirin is not effectively reducing clot formation risk, suggesting the need for alternative therapeutic strategies.

Offered by DNA Labs UAE, the test is priced at 2750 AED. Conducting this test can be crucial for individuals on aspirin therapy, especially those at high risk for cardiovascular events, to ensure that they are receiving the most effective treatment for their condition. By tailoring therapy based on the test results, healthcare providers can better manage the risk of heart attacks and strokes in their patients.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ASPIRIN RESISTANCE 11-DEHYDROTHROMBOXANE B2 Test

Test Name: ASPIRIN RESISTANCE 11-DEHYDROTHROMBOXANE B2 Test

Components: Price: 2750.0 AED

Sample Condition: 5 mL (4 mL min.) urine in a special culture vacutainer tube available from LPL. Ship refrigerated or frozen. Duly filled Test Send Out Consent Form is mandatory.

Report Delivery: Sample by 7th of the month; Report after 2-3 weeks

Method: Immunoassay

Test type: Heart Diseases

Doctor: Physician

Test Department: OS

Pre Test Information: Duly filled Test Send Out Consent Form is mandatory.

Test Details

The ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2) test is a laboratory test used to determine if an individual is resistant to the effects of aspirin. Aspirin is commonly prescribed to prevent blood clot formation and reduce the risk of heart attacks and strokes. However, some individuals may not respond to aspirin treatment due to aspirin resistance.

The test measures the level of 11-dehydrothromboxane B2 (11-dTXB2) in the blood or urine. Thromboxane is a substance that promotes blood clotting, and aspirin works by inhibiting its production. Therefore, a high level of 11-dTXB2 indicates that aspirin is not effectively inhibiting thromboxane production, suggesting aspirin resistance.

The test is typically performed in individuals who are not responding to aspirin therapy, despite taking the recommended dosage. It can help identify patients who may require alternative antiplatelet medications or higher doses of aspirin.

It is important to note that aspirin resistance is not a well-defined condition, and its clinical significance is still a subject of debate. Some studies suggest that aspirin resistance may be associated with an increased risk of cardiovascular events, while others do not find a significant correlation.

If you suspect aspirin resistance or have concerns about your response to aspirin therapy, it is recommended to consult with a healthcare professional who can evaluate your specific situation and provide appropriate guidance.

Test Name ASPIRIN RESISTANCE 11-DEHYDROTHROMBOXANE B2 Test
Components
Price 2750.0 AED
Sample Condition 5 mL (4 mL min.) urine in a special culture vacutainer tube available from LPL. Ship refrigerated or frozen. Duly filled Test Send Out Consent Formis mandatory.
Report Delivery Sample by 7th of the month; Report after 2-3 weeks
Method Immunoassay
Test type Heart Diseases
Doctor Physician
Test Department: OS
Pre Test Information Duly filled Test Send Out Consent Formis mandatory.
Test Details

The ASPIRIN RESISTANCE (11-DEHYDROTHROMBOXANE B2) test is a laboratory test used to determine if an individual is resistant to the effects of aspirin. Aspirin is commonly prescribed to prevent blood clot formation and reduce the risk of heart attacks and strokes. However, some individuals may not respond to aspirin treatment due to aspirin resistance.

The test measures the level of 11-dehydrothromboxane B2 (11-dTXB2) in the blood or urine. Thromboxane is a substance that promotes blood clotting, and aspirin works by inhibiting its production. Therefore, a high level of 11-dTXB2 indicates that aspirin is not effectively inhibiting thromboxane production, suggesting aspirin resistance.

The test is typically performed in individuals who are not responding to aspirin therapy, despite taking the recommended dosage. It can help identify patients who may require alternative antiplatelet medications or higher doses of aspirin.

It is important to note that aspirin resistance is not a well-defined condition, and its clinical significance is still a subject of debate. Some studies suggest that aspirin resistance may be associated with an increased risk of cardiovascular events, while others do not find a significant correlation.

If you suspect aspirin resistance or have concerns about your response to aspirin therapy, it is recommended to consult with a healthcare professional who can evaluate your specific situation and provide appropriate guidance.